InvestorsHub Logo
Followers 7
Posts 327
Boards Moderated 0
Alias Born 02/05/2017

Re: None

Friday, 05/07/2021 7:13:36 PM

Friday, May 07, 2021 7:13:36 PM

Post# of 118364
rgbp

Item 8.01 Other Events.

Regen Biopharma, Inc. (the “Company”) has begun the process of reviving patent applications of the Company filed with the United States Patent and Trademark Office (“USPTO”) which have been classified as abandoned by the USPTO.

Legal services in connection with the abovementioned revival activities are being provided by Marc Baumgartner of Baumgartner Patent Law. Mr. Baumgartner has over 20 years of experience in the field of intellectual property law.